Benefit/Risk Assessment for Breast Cancer Chemoprevention With Raloxifene or Tamoxifen for Women Age 50 Years or Older

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

2002 • 15,184 citations

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1998 • 5,487 citations

Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy

2004 • 4,391 citations

Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>

1999 • 3,362 citations

Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually

1989 • 3,239 citations

Design of the Women’s Health Initiative Clinical Trial and Observational Study

1998 • 2,456 citations

Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes<SUBTITLE>The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial</SUBTITLE>

2006 • 1,621 citations

Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women

2006 • 1,014 citations

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

1998 • 890 citations

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women

1998 • 774 citations

Validation Studies for Models Projecting the Risk of Invasive and Total Breast Cancer Incidence

1999 • 743 citations

First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial

2002 • 731 citations

Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer

1999 • 676 citations

IX: Summary of Meta-Analyses of Therapies for Postmenopausal Osteoporosis

2002 • 621 citations

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer

2010 • 614 citations

Long-Term Results of Tamoxifen Prophylaxis for Breast Cancer--96-Month Follow-up of the Randomized IBIS-I Trial

2007 • 524 citations

Twenty-Year Follow-up of the Royal Marsden Randomized, Double-Blinded Tamoxifen Breast Cancer Prevention Trial

2007 • 417 citations

Tamoxifen for Prevention of Breast Cancer

2003 • 351 citations

Projecting Individualized Absolute Invasive Breast Cancer Risk in African American Women

2007 • 332 citations

American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction

2009 • 283 citations

Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes. The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial

2006 • 264 citations

Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer

2009 • 97 citations

Effectiveness of preventive interventions in BRCA1/2 gene mutation carriers: A systematic review

2007 • 66 citations